The US Department of Veterans Affairs is providing ReWalk Personal exoskeleton systems for all qualifying veterans.
The share price of ReWalk Robotics Ltd. (RWLK) has doubled following the company's announcement that the US Department of Veterans Affairs (VA) had issued a national policy for the evaluation, training and procurement of ReWalk Personal exoskeleton systems for all qualifying veterans across the United States. The VA policy, which is exclusive to ReWalk Robotics exoskeleton systems, is the first national coverage policy in the United States for qualifying individuals who have suffered spinal cord injury.
"This historic policy will provide access to our life-changing technology for thousands of veterans across America," said ReWalk CEO Larry Jasinski. "We want all U.S. veterans with a spinal cord injury to know that they now have a path to securing their own ReWalk Personal exoskeleton system. The policy outlines a sound process to educate, train and importantly, to provide individual veterans with a ReWalk Personal device so that they may walk at home and in the community. We expect this landmark national policy will substantially improve the health and quality of life of many veterans in the years ahead," Jasinski added
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again.
Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
Current ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs. The system uses patented motion sensing technology along with battery-powered motorized legs powering knee and hip movement which is controlled by proprietary on-board computers and software.
The ReWalkŠ systems allows the user to sit, stand, walk, turn and has the ability to climb and descend stairs*. ReWalk users are able to independently operate the systems.
ReWalk received US FDA clearance to market in 2014 and is the only exoskeleton with US FDA clearance.